These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3260071)

  • 61. High-level production and isolation of human recombinant alpha 1-proteinase inhibitor in yeast.
    Hoylaerts M; Weyens A; Bollen A; Harford N; Cabezón T
    FEBS Lett; 1986 Aug; 204(1):83-7. PubMed ID: 3488920
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Purification and characterization of a multicatalytic high-molecular-mass proteinase from rat skeletal muscle.
    Dahlmann B; Kuehn L; Rutschmann M; Reinauer H
    Biochem J; 1985 May; 228(1):161-70. PubMed ID: 3890839
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Application of 2-D free-flow electrophoresis/RP-HPLC for proteomic analysis of human plasma depleted of multi high-abundance proteins.
    Moritz RL; Clippingdale AB; Kapp EA; Eddes JS; Ji H; Gilbert S; Connolly LM; Simpson RJ
    Proteomics; 2005 Aug; 5(13):3402-13. PubMed ID: 16052629
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Isolation and characterization of alpha 1-protease inhibitor from canine plasma.
    Melgarejo T; Williams DA; Griffith G
    Am J Vet Res; 1996 Mar; 57(3):258-63. PubMed ID: 8669751
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Purification of human butyrylcholinesterase from frozen Cohn fraction IV-4 by ion exchange and Hupresin affinity chromatography.
    Schopfer LM; Lockridge O; David E; Hinrichs SH
    PLoS One; 2019; 14(1):e0209795. PubMed ID: 30625168
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biochemical comparison of four commercially available human α
    Boerema DJ; An B; Gandhi RP; Papineau R; Regnier E; Wilder A; Molitor A; Tang AP; Kee SM
    Biologicals; 2017 Nov; 50():63-72. PubMed ID: 28882403
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Yield improvement for manufacture of alpha-proteinase inhibitor.
    Zimmerman TP
    Vox Sang; 2006 Nov; 91(4):309-15. PubMed ID: 17105606
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Isolation and characterization of sheep alpha 1-proteinase inhibitor.
    Mistry R; Snashall PD; Totty N; Guz A; Tetley TD
    Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):685-90. PubMed ID: 1899999
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Purification and characterization of rat plasma alpha-1-antitrypsin.
    Takahara H; Nakayama H; Sinohara H
    J Biochem; 1980 Aug; 88(2):417-24. PubMed ID: 6968311
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quantitative immunoelectrophoresis of proteins in human erythrocyte membranes. Analysis of protein bands obtained by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
    Bjerrum OJ; Bhakdi S; Bog-Hansen TC; Knüfermann H; Wallach DF
    Biochim Biophys Acta; 1975 Nov; 406(4):489-504. PubMed ID: 52375
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Isolation and characterization of alpha 1-antitrypsin in PAS-positive hepatic granules from rats with experimental alpha 1-antitrypsin deficiency.
    Bolmer S; Kleinerman J
    Am J Pathol; 1986 May; 123(2):377-89. PubMed ID: 3085511
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Studies on the interactions of human pancreatic elastase 2 with human alpha 1-proteinase inhibitor and alpha 1-antichymotrypsin.
    Davril M; Laine A; Hayem A
    Biochem J; 1987 Aug; 245(3):699-704. PubMed ID: 3499146
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Isolation of antithrombin III from normal and alpha1-antitrypsin-deficient human plasma.
    Borsodi AD; Bradshaw RA
    Thromb Haemost; 1977 Aug; 38(2):475-85. PubMed ID: 304258
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ontogeny and tissue distribution of alpha-1-antitrypsin of the mouse.
    Lamontagne L; Gauldie J; Koj A
    Biochim Biophys Acta; 1981 Nov; 662(1):15-21. PubMed ID: 6796124
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Isolation and characterization of alpha-1-antitrypsin from the Cohn fraction IV-I of human plasma.
    Glaser CB; Karic L; Fallat R
    Prep Biochem; 1975; 5(4):333-48. PubMed ID: 1081224
    [No Abstract]   [Full Text] [Related]  

  • 76. Exposure of hydrophobic moieties promotes the selective degradation of hydrogen peroxide-modified hemoglobin by the multicatalytic proteinase complex, proteasome.
    Giulivi C; Pacifici RE; Davies KJ
    Arch Biochem Biophys; 1994 Jun; 311(2):329-41. PubMed ID: 8203895
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Replacement therapy for alpha-1-protease inhibitor deficiency in PiZ subjects with chronic obstructive lung disease.
    Schmidt EW; Rasche B; Ulmer WT; Konietzko N; Becker M; Fallise JP; Lorenz J; Ferlinz R
    Am J Med; 1988 Jun; 84(6A):63-9. PubMed ID: 3289388
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Natural history of alpha-1-protease inhibitor deficiency.
    Hutchison DC
    Am J Med; 1988 Jun; 84(6A):3-12. PubMed ID: 3289386
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of urokinase by complex formation with human alpha1-antitrypsin.
    Clemmensen I; Christensen F
    Biochim Biophys Acta; 1976 Apr; 429(2):591-9. PubMed ID: 1083251
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Purification and characterization of alpha-N-acetylgalactosaminidase from Clostridium perfringens.
    Hsieh HY; Mitra M; Wells DC; Smith D
    IUBMB Life; 2000 Aug; 50(2):91-7. PubMed ID: 11185964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.